post-transplant cyclophosphamide and unmet needs in gvhd
Published 4 years ago • 235 plays • Length 2:52Download video MP4
Download video MP3
Similar videos
-
4:07
the potential for post-transplant cyclophosphamide for gvhd
-
2:05
post-transplant cyclophosphamide in chronic gvhd
-
4:27
posttransplant cyclophosphamide for gvhd
-
1:11
post-transplant cyclophosphamide versus standard gvhd prophylaxis after allosct for aml & mds
-
3:01
gvhd prophylaxis with post-transplant cyclophosphamide
-
3:23
the use of post-transplant cyclophosphamide
-
0:43
post-transplant cyclophosphamide, tacrolimus, and mmf for gvhd in the myeloablative setting
-
4:25
post-transplant cyclophosphamide mechanisms
-
1:53
advances and unmet needs in chronic gvhd
-
6:30
gvhd outcomes with post-transplant cyclophosphamide, tacrolimus, and... in stem cell transplant
-
1:15
ash 2022 lba: post-transplant cyclophosphamide, tacrolimus & mmf for gvhd prophylaxis in ric
-
2:49
cyclophosphamide vs atg for gvhd prevention in haplo-hsct for adult all
-
6:05
is it possible to efficiently prevent gvhd with a modified ptcy dosing schedule?
-
5:03
acute gvhd: grade, risk, and prophylaxis
-
43:48
post transplantation cyclophosphamide based graft-versus-host disease prophylaxis
-
3:11
the future of treating gvhd
-
0:42
vedolizumab for gi acute gvhd prophylaxis after allogeneic transplantation
-
3:23
novel prophylactic therapies available before and after transplantation to reduce the risk of gvhd
-
4:17
novel-based approaches and the future of acute gvhd